Trademark: 88916001
Word
REVEMBEQ
Status
Dead
Status Code
606
Status Date
Monday, November 1, 2021
Serial Number
88916001
Mark Type
4000
Filing Date
Thursday, May 14, 2020
Published for Opposition
Tuesday, August 4, 2020
Abandoned Date
Monday, November 1, 2021

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Trademark Events
Nov 1, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 1, 2021
Abandonment - No Use Statement Filed
Jan 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 27, 2021
Extension 1 Granted
Jan 27, 2021
Extension 1 Filed
Jan 27, 2021
Teas Extension Received
Sep 29, 2020
Noa E-Mailed - Sou Required From Applicant
Aug 4, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 4, 2020
Published For Opposition
Jul 15, 2020
Notification Of Notice Of Publication E-Mailed
Jun 26, 2020
Approved For Pub - Principal Register
Jun 23, 2020
Assigned To Examiner
May 28, 2020
New Application Office Supplied Data Entered In Tram
May 18, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24